131 related articles for article (PubMed ID: 38244725)
1. Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
Sakano Y; Sakano K; Hurrell BP; Helou DG; Shafiei-Jahani P; Kazemi MH; Li X; Shen S; Hilser JR; Hartiala JA; Allayee H; Barbers R; Akbari O
J Allergy Clin Immunol; 2024 May; 153(5):1406-1422.e6. PubMed ID: 38244725
[TBL] [Abstract][Full Text] [Related]
2. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
4. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity.
Thio CL; Lai AC; Chi PY; Webster G; Chang YJ
J Allergy Clin Immunol; 2019 Sep; 144(3):682-697.e9. PubMed ID: 30914379
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
7. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity.
Howard E; Lewis G; Galle-Treger L; Hurrell BP; Helou DG; Shafiei-Jahani P; Painter JD; Muench GA; Soroosh P; Akbari O
J Allergy Clin Immunol; 2021 Apr; 147(4):1281-1295.e5. PubMed ID: 32905799
[TBL] [Abstract][Full Text] [Related]
8. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
9. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
10. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
11. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
12. Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity.
Maazi H; Banie H; Aleman Muench GR; Patel N; Wang B; Sankaranarayanan I; Bhargava V; Sato T; Lewis G; Cesaroni M; Karras J; Das A; Soroosh P; Akbari O
J Allergy Clin Immunol; 2018 Mar; 141(3):893-905.e6. PubMed ID: 28579374
[TBL] [Abstract][Full Text] [Related]
13. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.
Christianson CA; Goplen NP; Zafar I; Irvin C; Good JT; Rollins DR; Gorentla B; Liu W; Gorska MM; Chu H; Martin RJ; Alam R
J Allergy Clin Immunol; 2015 Jul; 136(1):59-68.e14. PubMed ID: 25617223
[TBL] [Abstract][Full Text] [Related]
14. CD226 Deficiency Alleviates Murine Allergic Rhinitis by Suppressing Group 2 Innate Lymphoid Cell Responses.
Xie Y; Zhang Y; Zhu T; Ma J; Duan C; Yang L; Wang T; Zhuang R; Bian K; Lu L
Mediators Inflamm; 2022; 2022():1756395. PubMed ID: 35846105
[TBL] [Abstract][Full Text] [Related]
15. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
[TBL] [Abstract][Full Text] [Related]
16. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
17. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
18. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
Drake LY; Iijima K; Kita H
Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
20. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Lo R; Howard E; Hurrell BP; Galle-Treger L; Painter JD; Lewis G; Soroosh P; Sharpe AH; Akbari O
Nat Commun; 2020 Aug; 11(1):3998. PubMed ID: 32778730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
